The Italian Association of Medical Oncology has renewed its management positions. He officially takes over the leadership Francesco PerroneDirector of the Complex Clinical Trials Structure of the Pascale Cancer Institute of Naples, while the new President elected is Massimo Di MaioDirector of University Medical Oncology of the Molinette Hospital, AOU Città della Salute e della Scienza of Turin who will take office in 2025.
The rest of the 2023/2025 national board of directors is made up of the new Secretary Nicola Silvestris – professor of medical oncology at the University of Messina and national councilor of the Southern Italy Oncology Group – and by the new Treasurer Rossana Berardi – Professor of Medical Oncology at the Polytechnic University of Marche, Director of the Oncology Clinic at the AOU of Marche, President of Women For Oncology Italy and coordinator of the One Healthon project. The national councilors are: Antonella Brunello, Giuseppe Curigliano, Alessandra Fabi, Matteo Lambertini, Tiziana Pia Latiano, Nicla Maria La Verde, Filippo Pietrantonio And Marcellus Tiseo. The election took place during the XXV National Congress of the scientific society which ended yesterday in Rome, and saw the participation of over 3 thousand specialists from all over Italy.
The new national president
Neapolitan, born in 1962, married and father of three children since 1995 Francesco Perrone he carried out planning, management, analysis and publication of clinical trials at the National Cancer Institute of Naples: “We look with confidence and optimism at the diagnostic and therapeutic progress, which is changing the face of our discipline for the better. However, we cannot ignore the problems that concern the sustainability of this medical-scientific progress. The Italian Medicines Agency is a necessary partner of ours, with which we want to have a privileged relationship – explains the AIOM President -. This is why we ask that the reform of the regulatory body be completed as soon as possible.”
Born in 1975, also Neapolitan by origin but Turin by adoption, Massimo Di Maio he is full professor of Medical Oncology at the Department of Oncology of the University of Turin and Director of University Medical Oncology of the Molinette Hospital, AOU Città della Salute e della Scienza of Turin: “I thank all the AIOM members for the trust placed. I served as National Secretary of the Scientific Society for four years and I understood how important communication between members is through all means of communication. We must therefore also perfect our internal organization to make our Scientific Society feel more and more like a common home for all medical specialists. About half of the members are represented by young colleagues and I will try to give ever greater weight to their initiatives. Medical oncology is rapidly evolving and our knowledge must be constantly updated. We must above all teach the young people of AIOM the methodology of clinical research, so essential in oncology, and to have a critical spirit towards new scientific evidence”.
In addition to training young oncologists, the objectives are aimed at supporting Italian oncology which is based on universality, combating territorial disparities, especially in access to treatments and the best possible assistance. And, obviously, to strengthen dialogue with national and regional health institutions, to find new solutions to problems. “Always with a view to guaranteeing the most effective and innovative therapies for everyone, research must be encouraged, which is itself part of the treatment – concludes Di Maio – And the figure of the Study coordinator, i.e. the professional who coordinates the non-medical activities envisaged, must be further valorised from clinical studies. All these points will be at the center of my future presidency of AIOM and I intend to carry them forward with the precious help of the new National Board of Directors”.